Copyright Reports & Markets. All rights reserved.

Global Retinoic Acid Receptor Alpha Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Retinoic Acid Receptor Alpha Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Retinoic Acid Receptor Alpha Market Size Growth Rate by Product
      • 1.4.2 Alitretinoin
      • 1.4.3 IRX-5183
      • 1.4.4 SBD-073
      • 1.4.5 Tamibarotene
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Retinoic Acid Receptor Alpha Market Size Growth Rate by End User
      • 1.5.2 Myelodysplastic Syndrome
      • 1.5.3 Acute Myelocytic Leukemia
      • 1.5.4 Hormone Senstive Breast Cancer
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Retinoic Acid Receptor Alpha Market Size
      • 2.1.1 Global Retinoic Acid Receptor Alpha Revenue 2014-2025
      • 2.1.2 Global Retinoic Acid Receptor Alpha Sales 2014-2025
    • 2.2 Retinoic Acid Receptor Alpha Growth Rate by Regions
      • 2.2.1 Global Retinoic Acid Receptor Alpha Sales by Regions
      • 2.2.2 Global Retinoic Acid Receptor Alpha Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Retinoic Acid Receptor Alpha Sales by Manufacturers
      • 3.1.1 Retinoic Acid Receptor Alpha Sales by Manufacturers
      • 3.1.2 Retinoic Acid Receptor Alpha Sales Market Share by Manufacturers
      • 3.1.3 Global Retinoic Acid Receptor Alpha Market Concentration Ratio (CR5 and HHI)
    • 3.2 Retinoic Acid Receptor Alpha Revenue by Manufacturers
      • 3.2.1 Retinoic Acid Receptor Alpha Revenue by Manufacturers (2014-2019)
      • 3.2.2 Retinoic Acid Receptor Alpha Revenue Share by Manufacturers (2014-2019)
    • 3.3 Retinoic Acid Receptor Alpha Price by Manufacturers
    • 3.4 Retinoic Acid Receptor Alpha Manufacturing Base Distribution, Product Types
      • 3.4.1 Retinoic Acid Receptor Alpha Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Retinoic Acid Receptor Alpha Product Type
      • 3.4.3 Date of International Manufacturers Enter into Retinoic Acid Receptor Alpha Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Retinoic Acid Receptor Alpha Sales by Product
    • 4.2 Global Retinoic Acid Receptor Alpha Revenue by Product
    • 4.3 Retinoic Acid Receptor Alpha Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Retinoic Acid Receptor Alpha Breakdown Data by End User

    6 North America

    • 6.1 North America Retinoic Acid Receptor Alpha by Countries
      • 6.1.1 North America Retinoic Acid Receptor Alpha Sales by Countries
      • 6.1.2 North America Retinoic Acid Receptor Alpha Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Retinoic Acid Receptor Alpha by Product
    • 6.3 North America Retinoic Acid Receptor Alpha by End User

    7 Europe

    • 7.1 Europe Retinoic Acid Receptor Alpha by Countries
      • 7.1.1 Europe Retinoic Acid Receptor Alpha Sales by Countries
      • 7.1.2 Europe Retinoic Acid Receptor Alpha Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Retinoic Acid Receptor Alpha by Product
    • 7.3 Europe Retinoic Acid Receptor Alpha by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Retinoic Acid Receptor Alpha by Countries
      • 8.1.1 Asia Pacific Retinoic Acid Receptor Alpha Sales by Countries
      • 8.1.2 Asia Pacific Retinoic Acid Receptor Alpha Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Retinoic Acid Receptor Alpha by Product
    • 8.3 Asia Pacific Retinoic Acid Receptor Alpha by End User

    9 Central & South America

    • 9.1 Central & South America Retinoic Acid Receptor Alpha by Countries
      • 9.1.1 Central & South America Retinoic Acid Receptor Alpha Sales by Countries
      • 9.1.2 Central & South America Retinoic Acid Receptor Alpha Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Retinoic Acid Receptor Alpha by Product
    • 9.3 Central & South America Retinoic Acid Receptor Alpha by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Retinoic Acid Receptor Alpha by Countries
      • 10.1.1 Middle East and Africa Retinoic Acid Receptor Alpha Sales by Countries
      • 10.1.2 Middle East and Africa Retinoic Acid Receptor Alpha Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Retinoic Acid Receptor Alpha by Product
    • 10.3 Middle East and Africa Retinoic Acid Receptor Alpha by End User

    11 Company Profiles

    • 11.1 3SBio Inc
      • 11.1.1 3SBio Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 3SBio Inc Retinoic Acid Receptor Alpha Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 3SBio Inc Retinoic Acid Receptor Alpha Products Offered
      • 11.1.5 3SBio Inc Recent Development
    • 11.2 Io Therapeutics Inc
      • 11.2.1 Io Therapeutics Inc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Io Therapeutics Inc Retinoic Acid Receptor Alpha Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Io Therapeutics Inc Retinoic Acid Receptor Alpha Products Offered
      • 11.2.5 Io Therapeutics Inc Recent Development
    • 11.3 Phosphagenics Ltd
      • 11.3.1 Phosphagenics Ltd Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Phosphagenics Ltd Retinoic Acid Receptor Alpha Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Phosphagenics Ltd Retinoic Acid Receptor Alpha Products Offered
      • 11.3.5 Phosphagenics Ltd Recent Development
    • 11.4 Sol-Gel Technologies Ltd
      • 11.4.1 Sol-Gel Technologies Ltd Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sol-Gel Technologies Ltd Retinoic Acid Receptor Alpha Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sol-Gel Technologies Ltd Retinoic Acid Receptor Alpha Products Offered
      • 11.4.5 Sol-Gel Technologies Ltd Recent Development

    12 Future Forecast

    • 12.1 Retinoic Acid Receptor Alpha Market Forecast by Regions
      • 12.1.1 Global Retinoic Acid Receptor Alpha Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Retinoic Acid Receptor Alpha Revenue Forecast by Regions 2019-2025
    • 12.2 Retinoic Acid Receptor Alpha Market Forecast by Product
      • 12.2.1 Global Retinoic Acid Receptor Alpha Sales Forecast by Product 2019-2025
      • 12.2.2 Global Retinoic Acid Receptor Alpha Revenue Forecast by Product 2019-2025
    • 12.3 Retinoic Acid Receptor Alpha Market Forecast by End User
    • 12.4 North America Retinoic Acid Receptor Alpha Forecast
    • 12.5 Europe Retinoic Acid Receptor Alpha Forecast
    • 12.6 Asia Pacific Retinoic Acid Receptor Alpha Forecast
    • 12.7 Central & South America Retinoic Acid Receptor Alpha Forecast
    • 12.8 Middle East and Africa Retinoic Acid Receptor Alpha Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Retinoic Acid Receptor Alpha Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Retinoic Acid Receptor Alpha market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Retinoic Acid Receptor Alpha market based on company, product type, end user and key regions.

      This report studies the global market size of Retinoic Acid Receptor Alpha in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Retinoic Acid Receptor Alpha in these regions.
      This research report categorizes the global Retinoic Acid Receptor Alpha market by top players/brands, region, type and end user. This report also studies the global Retinoic Acid Receptor Alpha market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      3SBio Inc
      Io Therapeutics Inc
      Phosphagenics Ltd
      Sol-Gel Technologies Ltd

      Market size by Product
      Alitretinoin
      IRX-5183
      SBD-073
      Tamibarotene
      Others
      Market size by End User
      Myelodysplastic Syndrome
      Acute Myelocytic Leukemia
      Hormone Senstive Breast Cancer
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Retinoic Acid Receptor Alpha market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Retinoic Acid Receptor Alpha market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Retinoic Acid Receptor Alpha companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Retinoic Acid Receptor Alpha submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Retinoic Acid Receptor Alpha are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Retinoic Acid Receptor Alpha market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now